COMMUNIQUÉS West-GlobeNewswire

RadNet, Inc. Announces Date of its First Quarter 2019 Financial Results Conference Call
03/05/2019
LOS ANGELES, May 02, 2019 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT) , a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient [...]
Avricore Health Announces Late Filing of Annual Financial Statements and Management Cease Trade Order
02/05/2019
Vancouver, May 02, 2019 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR) (“Avricore Health” or the “Company”) announced today that as a result of delays in completion of its audit, the Company did not file its [...]
Resverlogix Announces 3-Month Loan Extension
02/05/2019
CALGARY, Alberta, May 02, 2019 (GLOBE NEWSWIRE) -- Resverlogix Corp. (“Resverlogix” or the "Company") (TSX: RVX) today announces that it has entered into an amending agreement with Third Eye Capital (acting as agent for [...]
European Medicines Agency Recommends Orphan Drug Designation for Relacorilant to Treat Patients with Cushing’s Syndrome
02/05/2019
MENLO PARK, Calif., May 02, 2019 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of drugs to treat severe metabolic, oncologic [...]
Osmotica Pharmaceuticals plc to Provide First Quarter 2019 Business and Financial Update on May 9, 2019
02/05/2019
BRIDGEWATER, N.J., May 02, 2019 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (“Osmotica” or the “Company”) (Nasdaq: OSMT), a fully integrated biopharmaceutical company, today announced that the Company will release [...]
R1 to Present at the Bank of America Merrill Lynch 2019 Health Care Conference
02/05/2019
CHICAGO, May 02, 2019 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-enabled revenue cycle management services to healthcare providers, today announced its management team will present [...]
Dynavax Announces First Patient Enrolled in Study of HEPLISAV-B® [Hepatitis B Vaccine, Recombinant (Adjuvanted)] in Adults With End-Stage Renal Disease
02/05/2019
Trial to evaluate immunogenicity and safety of Hepatitis B vaccine, HEPLISAV-B, in patients with end-stage renal disease who are initiating or undergoing dialysis BERKELEY, Calif., May 02, 2019 (GLOBE NEWSWIRE) -- [...]
Coherus BioSciences and Amgen Settle Trade Secrets Action
02/05/2019
Coherus Continues to Commercialize UDENYCA® Across All Segments REDWOOD CITY, Calif., May 02, 2019 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced that Amgen and Coherus have [...]
Novartis to highlight extensive long-term safety and efficacy data of Aimovig® across the spectrum of migraine at AAN
02/05/2019
After long-term Aimovig (erenumab) treatment, two-thirds of chronic migraine patients converted to episodic migraine, experiencing 11 fewer migraine days per month on average Separate study showed the majority of [...]
Rockwell Medical, Inc. to Discuss First Quarter 2019 Financial Results on May 9, 2019
02/05/2019
WIXOM, Mich., May 02, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. ("Rockwell Medical" or the “Company”) (Nasdaq: RMTI) today announced that the Company will release its 2019 first quarter financial results on [...]
Idera Pharmaceuticals Reports First Quarter 2019 Financial Results and Provides Corporate Update
02/05/2019
EXTON, Pa., May 02, 2019 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (“Idera”) (NASDAQ: IDRA), a clinical-stage biopharmaceutical company focused on the development, and ultimately the commercialization, of [...]
Melinta Therapeutics to Report First Quarter 2019 Financial Results on May 9, 2019
02/05/2019
MORRISTOWN, N.J., May 02, 2019 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage company focused on the development and commercialization of novel antibiotics to treat serious bacterial [...]
Adverum Biotechnologies Announces Board Changes
02/05/2019
Independent Directors Rekha Hemrajani, James Scopa and Mark Lupher Added to the Board Patrick Machado Appointed as Board Chair; Paul Cleveland Retires from the Board MENLO PARK, Calif., May 02, 2019 (GLOBE NEWSWIRE) -- [...]
Zafgen to Announce First Quarter 2019 Financial Results
02/05/2019
BOSTON, May 02, 2019 (GLOBE NEWSWIRE) -- Zafgen, Inc. (Nasdaq:ZFGN), a clinical-stage biopharmaceutical company leveraging its proprietary knowledge of MetAP2 systems biology to develop novel therapies for patients [...]
Geron Corporation Reports First Quarter 2019 Financial Results
02/05/2019
MENLO PARK, Calif., May 02, 2019 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today reported financial results for the first quarter ended March 31, 2019. As of the quarter-end, the Company had approximately $ [...]
Inspire Medical Systems, Inc. to Present at the Bank of America Merrill Lynch Health Care Conference 2019
02/05/2019
MINNEAPOLIS, May 02, 2019 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative and minimally invasive [...]
Globus Medical Reports First Quarter 2019 Results
02/05/2019
AUDUBON, Pa., May 02, 2019 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced its financial results for the first quarter ended March 31, 2019. Worldwide [...]
Agile Therapeutics Reports First Quarter 2019 Financial Results
02/05/2019
Company Plans to Resubmit Twirla® NDA in Second Quarter of 2019 Cash Expected to Enable Company to Fund Operations into the Fourth Quarter of 2019 PRINCETON, N.J., May 02, 2019 (GLOBE NEWSWIRE) -- Agile Therapeutics, [...]
Reata Announces Presentation at the Annual CKD3 Chronic Kidney Disease Drug Development Summit
02/05/2019
IRVING, Texas, May 02, 2019 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Nasdaq: RETA), a clinical-stage biopharmaceutical company, today announced that Colin Meyer, M.D., Reata’s Chief Medical Officer, will present [...]

Pages